Insulin sensitivity in clinically healthy individuals with microalbuminuria

Atherosclerosis

Volumn 119, Issue 1, 1996, Pages 69-76

  Jensen, Jan Skov ^a,b   Borch Johnsen, Knut ^c   Jensen, Gorm ^b   Feldt Rasmussen, Bo ^b  

^a STENO DIABETES CENTER   (Denmark)

^b Rigshospitalet   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Atherosclerotic vascular disease; Blood pressure; Body weight; Insulin sensitivity; Lipids; Microalbuminuria

Indexed keywords

ALBUMIN; INSULIN; LIPID;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

EID: 0030060272     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05631-9     Document Type: Article

References (41)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595.
2. DeFronzo RA and Ferrannini E. Insulin resistance - a multifaceted syndrome responsible for NIDDM, obesity hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173.
3. Ferrannini E, Haffner SM, Mitchell BD and Stern MP. Hyperinsulinaemia: the key feature of cardiovascular and metabolic syndrome. Diabetologia 1991;34:416.
4. Messent JWC, Elliot TG, Hill RD, Jarrett RJ, Keen H and Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992;41:836.
5. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U and Murrells TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984;1:17.
6. Schmitz A and Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 1988;5:1126.
7. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP and Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736.
8. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R and Viberti GC. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993;342:883.
9. Groop L, Ekstrand A, Forsblom C, Widén E, Groop P-H Teppo A-M and Eriksson J. Insulin resistance, hypertension and microalbuminuria in patients with Type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia 1993: 36:642.
10. Nosadini R, Cipollina MR, Solini A, Sambataro A, Dona A, Fioretto P, Brocco E, Muollo B and Frigato F. Close relationship between microalbuminuria and insulin resistance in essential hypertension and non-insulin-dependent diabetes mellitus. J Am Soc Nephrol 1992;3:S56.
11. Yudkin JS, Forrest RD and Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988;ii:530.
12. Damsgaard EM, Froland A, Jorgensen OD and Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990;300: 297.
13. Damsgaard EM, Froland A, Jorgensen OD and Mogensen CE. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992;41:731.
14. Jensen JS, Borch-Johnsen K, Jensen G and Feldt-Rasmussen B. Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis 1995;112:245.
15. Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari G, Natali A, Ferrannini E and Campese VM. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 1994: 23(1):681.
16. The Copenhagen City Heart Study Group. The Copenhagen City Heart Study. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). Scand J Soc Med 1989;170(Suppl 41):1.
17. Jensen G. Epidemiology of chest pain and angina pectoris - with special reference to treatment needs. Acta Med Scand 1984;214(Suppl 682): 1.
18. Feldt-Rasmussen B, Dinesen B and Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985;45:539.
19. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen B, Jensen G and The Copenhagen City Heart Study Group. Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects. Scand J Clin Lab Invest 1993;53:867.
20. DeFronzo RA, Tobin JD and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;3:E214.
21. Andersen L, Dinesen B, Jorgensen PN, Poulsen F and Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993;39:578.
22. Heding LG, Radioimmunological determination of human C-peptide in serum. Diabetologia 1975;11:541.
23. Faber OK, Markussen J, Naithani VK and Binder C. Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin. Hoppe-Seyler's Z Physiol Chem 1976;357:751.
24. Haffner SM, Stern MP, Gruber MKK, Hazuda HP, Mitchell BD and Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990;10:727.
25. Winocour PH, Harland JOE, Millar JP, Laker MF and Alberti KGMM. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 1992;93:71.
26. Woo J, Cockram CS, Swaminathan R, Lau E, Chan E and Cheung R. Microalbuminuria and other cardiovascular risk factors in non-diabetic subjects. Int J Cardiol 1992:37:345.
27. Yudkin JS. Microalbuminuria as a risk factor for cardiovascular disease in non-diabetic subjects. In: Crepaldi G, Tiengo A and Manzato E. (eds). Diabetes, Obesity and Hyperlipidemias: V. The Plurimetabolic Syndrome. Amsterdam: Elsevier Science Publishers, 1993;152.
28. Mykkänen L, Haffner SM, Kuusisto J, Pyörälä K, and Laakso M, Microalbuminuria precedes the development of NIDDM. Diabetes 1994;43:552.
29. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2:131.
30. Welborn TA and Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2:154.
31. Fontbonne AM, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE and Eschwège E. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study. 15-year follow-up. Diabetologia 1991;34:356.
32. Stout RW, Development of vascular lesions in insulin-treated animals fed a normal diet. Br Med J 1970;3:685.
33. Dimmitt SB, Lindquist TL, Mamotte CDS, Burke V and Beilin LJ. Urine albumin excretion in healthy subjects. J Hum Hypertens 1993;7:239.
34. Metcalf P, Baker J, Scott A, Wild C, Scragg R and Dryson E. Albuminuria in people at least 40 years old: effect of obesity, hypertension and hyperlipidemia. Clin Chem 1992;38:1802.
35. Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS and Haines AP. Microalbuminuria: associations with height and sex in non-diabetic subjects. Br Med J 1993;306:240.
36. Nestler JE, Barlascini O, Tetrault GA, Fratkin MJ, Clore JN and Blackard WG. Increased transcapillary escape rate of albumin in non-diabetic men in response to hyperinsulinemia. Diabetes 1990;39:1212.
37. Jensen JS, Borch-Johnsen K, Jensen G and Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (1995), 1995;88:629.
38. Bergman RN, Hope ID, Yang YJ, Watanabe RM, Meador MA, Youn JH and Ader M. Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 1989;5:411.
39. Mogensen CE. Frontiers in medicine. Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med 1994;235:297.
40. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A and Viberti GC. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1986;9(2):85.
41. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T and Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219.